Overview of Surveys with Fenfluramine-Phentermine
Notes:
6. Data were collected and analyzed from five separate echocardiographic-prevalence surveys performed on patients treated with fenfluramine-phentermine in combination after the July 8 FDA Advisory. Dr. Richard Bowen of Naples, FL, began performing cardiac tests on asymptomatic fenfluramine-phentermine treated patients in his practice. Dr. Mehmood Khan at Hennepin County Medical Center in Minneapolis, MN, received NIH and CDC funding to perform testing on subjects who were participating in a study of weight loss. Dr. Alan Glicklich, of Milwaukee, WI, also began performing echocardiograms on patients in his practice treated with fenfluramine-phentermine for more that 12 months. Susan Rasmussen, RN, collected test results and clinical data from patients who underwent echocardiography as part of a community outreach effort sponsored by the Hendricks Community Hospital, in Danville, IN. Drs. Thomas Wadden and Frank Silvestry, at the Hospital of the University of Pennsylvania, Philadelphia, PA, tested all fenfluramine-phentermine treated patients from a weight loss research study they recently completed.